glp 1 receptor agonist for weight loss Top GLP-1 Agonists Balance Efficacy, Safety What Are GLP-1 Agonists For

Description

This clinical trial did not include patients with T2D, and the emerging data suggests that the weight-loss effects of tirzepatide are reduced in patients with diabetes, a difference also observed in trials with 2.4 mg of semaglutide 2

According to the World Health Organization (WHO), the global prevalence of obesity has nearly tripled since 1975

NICE recommends that patients receive support from a multidisciplinary team delivering comprehensive weight management programs, emphasizing calorie restriction, increased physical activity, and behavioural interventions for long-term success by trained professionals [7]

95 Lixisenatide is a short-acting GLP-1RA agent, 96,97 and once-daily lixisenatide can improve patient compliance to a certain extent and reduce the occurrence of hypoglycemia